BIOTECH FONDS VLAANDEREN
People
3
Locations
1
Publications
38
Company Profile
Founded Date
December 28, 1994
Last Balance Sheet Year
2024
Juridical Form
Naamloze vennootschap
Enterprise Type
Rechtspersoon
Activity
No data available
Company Age
32 years
Contact Details
Unlock direct contact points, registry address detail, and website links for BIOTECH FONDS VLAANDEREN.
Unlock Contact Details
Reveal email, phone, website, and full registry contact information.
Create Free AccountHistorical Financials
| KPI | 2024 | 2023 | 2022 |
|---|---|---|---|
| Turnover | - | - | - |
| Gross Margin | - | - | - |
| Profit | -€1,640,956 (+64.4%) | -€4,604,192 (+18.7%) | -€5,662,227 (-295.5%) |
| EBITDA | -€239,523 (+33.3%) | -€359,107 (-61.1%) | -€222,957 (+51.4%) |
| Equity | €29,288,335 (-47.6%) | €55,929,292 (-7.6%) | €60,533,484 (-8.6%) |
| Debt | €157,226 (+1669.6%) | €8,885 (+72.0%) | €5,164 (-78.0%) |
| Total Assets | €29,445,568 (-47.4%) | €55,938,186 (-7.6%) | €60,538,648 (-8.6%) |
| Cash | €1,368,987 (-78.7%) | €6,423,941 (-82.3%) | €36,348,869 (+31554.1%) |
| FTE | - | - | - |
Unlock Full History
Create a free account to access up to 10 years of historical financial data for BIOTECH FONDS VLAANDEREN.
Create Free AccountFinancial Health
Ratio-level insight derived from the latest company and balance sheet data.
Current Ratio
29.6x
(-99.2%)
Quick Ratio
29.6x
(-99.2%)
Solvency
99.5%
(-0.5%)
Debt / Equity
0.0x
Unlock Advanced Metrics
Access the full ratio deck, benchmarking signals, and deeper profitability diagnostics.
Create Free AccountLocations & Footprint
Establishment
AddressOude Graanmarkt 63, 1000 Brussel, Belgium
Entity Network
First-level relations linked directly to BIOTECH FONDS VLAANDEREN. Unlock second-level relations for deeper graph exploration.
BIOTECH FONDS VLAANDEREN
Active
- ETHERNA IMMUNOTHERAPIES
Outgoing link
Administrator Legal - Participatiemaatschappij Vlaanderen
Incoming link
Administrator Legal - ViroVet
Outgoing link
Administrator Legal -
Elke Van De Walle
Incoming link
Administrator Natural -
Kenneth Wils
Incoming link
Administrator Natural - Aelin Therapeutics
Incoming link
Participating Interest - Aphea.Bio
Incoming link
Participating Interest - AUGUSTINE THERAPEUTICS
Incoming link
Participating Interest - Biotalys
Incoming link
Participating Interest - Confo Therapeutics
Incoming link
Participating Interest - Participatiemaatschappij Vlaanderen
Outgoing link
Participating Interest - reMYND
Incoming link
Participating Interest - ReWind Therapeutics
Incoming link
Participating Interest - ViroVet
Incoming link
Participating Interest - Aelin Therapeutics
Outgoing link
Shareholder Entity - Confo Therapeutics
Outgoing link
Shareholder Entity - ViroVet
Outgoing link
Shareholder Entity -
Michel Casselman
Incoming link
Administrator Legal Representative
Unlock Second-Level Relations
Expand beyond direct links to see second-level entities, people, and cross-company paths.
Free Sign UpManagement & Key People
Unlock linked people, governance roles, and enriched demographic signals associated with BIOTECH FONDS VLAANDEREN.
Management Profiles
Unlock directors, managers, role history, plus inferred gender and age where available.
Create Free Account